omalizumab
pharmaceutical drug
Press Enter · cited answer in seconds
0 sources
omalizumab
Summary
omalizumab is a type of chemical entity[1]. omalizumab has Wikipedia articles in 18 language editions, a strong signal of global cultural recognition.[2]
Key Facts
- omalizumab's instance of is recorded as type of chemical entity[3].
- omalizumab is a type of chemical compound[4].
- omalizumab is used for medication[5].
- omalizumab's Commons category is recorded as Omalizumab[6].
- omalizumab comprises carbon[7].
- omalizumab's has characteristic is recorded as biopharmaceutical[8].
- omalizumab's medical condition treated is recorded as angioedema[9].
- omalizumab's medical condition treated is recorded as status asthmaticus[10].
- omalizumab's medical condition treated is recorded as allergic bronchopulmonary aspergillosis[11].
- omalizumab's medical condition treated is recorded as respiratory disease[12].
- omalizumab's medical condition treated is recorded as urticaria[13].
- omalizumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'omalizumab'}[14].
- omalizumab's subject has role is recorded as anti-allergic agents[15].
- omalizumab's subject has role is recorded as antiasthmatic[16].
- omalizumab's subject has role is recorded as monoclonal antibody[17].
- omalizumab's legal status is recorded as boxed warning[18].
- omalizumab's active ingredient in is recorded as Xolair[19].
- omalizumab's has active ingredient is recorded as Omalizumab[20].
- omalizumab's defined daily dose is recorded as {'unit': 'Q3241121', 'amount': '+16.0'}[21].
Why It Matters
omalizumab has Wikipedia articles in 18 language editions, a strong signal of global cultural recognition.[2] omalizumab is known by 9 alternative names across languages and contexts.[22]